Lebanese Internal Security Chief Warns of Political Impact on Stability

Maj. Gen. Imad Othman honors officers retiring (ISF Website)
Maj. Gen. Imad Othman honors officers retiring (ISF Website)
TT

Lebanese Internal Security Chief Warns of Political Impact on Stability

Maj. Gen. Imad Othman honors officers retiring (ISF Website)
Maj. Gen. Imad Othman honors officers retiring (ISF Website)

In less than nine months, if the current political deadlock in Lebanon persists, the management of the Internal Security Forces (ISF), a pivotal sector in the country's security, will transition to interim management. This pattern follows that of many other affected official institutions due to the presidential vacancy.

Fundamental Christian factions have declined to make appointments in the absence of a president.

Nine months from now, give or take a week, the General Director of Lebanon’s ISF, Maj. Gen. Imad Othman, will reach the retirement age.

The notion of a vacuum doesn't exist in the realm of security; instead, there are makeshift measures that institutions resort to in order to fill the void.

However, this doesn’t necessarily mean that things will return to complete normalcy after this date, despite Othman’s attempt to instill a sense of reassurance.

“The institution is capable of continuing its duties; it is brimming with competencies,” Othman assured Asharq Al-Awsat.

Othman believes that Lebanon’s security forces are capable of persisting due to the mentality guiding its members and the discipline on which they are raised.

“There is a strong sense of responsibility, and that alone justifies the continued operation of the security forces despite all the challenges that Lebanon has faced since 2019, referring to the financial crisis that has hit the country and pushed the national currency’s exchange rate to unprecedented levels, consequently affecting the purchasing power of military salaries in general,” explained Othman.

The most compelling motivation for their continuity, however, lies in “the security forces’ understanding that there are those who desire to take their place and those who seek chaos instead of stability.”

“Our lives are built on caution against the unknown,” added Othman.

Moreover, the security forces had established a centralized administration for security decisions.

They formed mobile units to counter rioting, military forces for security intervention, and an information division for combined technical and military intervention.

Meanwhile, the small precincts dispersed throughout the country serve as vigilant eyes and ears, receiving complaints and preparing to address them.

Othman also expressed significant concern regarding the situation of the security forces due to “clear targeting.”

He doesn’t provide extensive details, but he said: “I sense a threat to the institution.”

“There are those who target it because it upholds security in the country.”

“I don't want to go into specifics, but there is a direct and unjustifiable targeting of the security forces.”

“However, this is an institution that has been around for over 160 years, and ending its role is not an easy task,” affirmed Othman.

Othman asserted that the security situation is under control.

He goes even further, affirming that the security situation is “stable.”

“We are pursuing crime and are capable of managing it,” he said.

“However, there are other diverse issues, such as security hotspots emerging in certain areas, taking on a military character, like the Palestinian camps where sporadic fighting occurs,” noted Othman.

Additionally, Othman points to another significant security concern, which is the Syrian displacement, with apprehensions that “security concerns might escalate due to it.”

“There are many crimes linked to the Syrian presence. This places pressure on the security forces and the prison infrastructure in Lebanon, as the number of Syrian prisoners is now approaching a third of the total prison population,” he explained.

“About 17.8% of convicts are Syrian and 43% of detainees are Syrian,” revealed Othman.

In short, Othman affirmed that crime control is very effective, but the danger lies in the political impact on security.

It’s usually difficult for a security figure to openly discuss politics, but the impression left by visitors to Othman suggests a profound dissatisfaction with the “casualness” with which some politicians approach security matters and their lack of concern for avoiding “red lines” as long as it benefits them.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.